Jacob Plieth
Journalist covering biopharma at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.
16912 followers
Lens Rankings
Journalism
#30 | 0.005026 | Stat News |
#7853 | 0.000014 | Bloomberg Opinion |
Science
#27 | 0.002182 | Biotech |
Culture and Political Economy
#463 | 0.000307 | Works in Progress |
#3005 | 0.000037 | Progress Studies |
Think Tanks
#2140 | 0.000070 | American Enterprise Institute |
#2140 | 0.000070 | National Bureau of Economic Research |
Venture Capital
#8653 | 0.000006 | A16Z |